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An investigation of the properties of TSH receptors on FRTL, cells using affinity labelling with a rz51-la- 
belled photoactive derivative of TSH is described. Our studies suggest that FRTL, cells contain 2 principal 
types of cell surface TSH receptors. One form, probably a precursor, consists of a single polypeptide chain 
(Mr 120000) with an intrachain loop of amino acids formed by a disulphide bridge. The other type of recep- 
tor consists of a water-soluble A chain (MT 55000) linked to an amphiphilic B chain (Mr 35000) by a 
disulphide bridge. The 2 chain structure isprobably derived from the single chain 120000 protein by enzy- 
matic cleavage of peptide sequences within the loop of amino acids formed by the intrachain disulphide 
bridge. 
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1. INTRODUCTION 
The continuous line of functioning rat thyroid 
cells (FRTL5) developed by Ambesi-Impiombato 
and his colleagues [l] have proved to be a most 
useful model for investigating the properties of 
thyroid cells. In particular the cells retain most of 
the features of the thyroid gland in vivo, including 
responsiveness to TSH and TSH receptor autoan- 
tibodies [2]. We now describe an investigation of 
the properties of TSH receptors on FRTLs cells us- 
ing affinity labelling with a 1251-labelled photoac- 
tive derivative of TSH. Our studies suggest that 
FRTLs cells contain 2 principal types of cell sur- 
face TSH receptors. One form, probably a precur- 
sor, consists of a single polypeptide chain M, 
120000, with an intrachain loop of amino acids, 
formed by a disulphide bridge. The other type of 
receptor consists of a water soluble A chain (M, 
55000) linked to an amphiphilic B chain (n/r, 
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35000) by a disulphide bridge. The 2 chain struc- 
ture is probably derived from the single chain 
12OOOB protein by enzymatic cleavage of peptide 
sequences within the loop of amino acids formed 
by the intrachain disulphide bridge. 
2. MATERIALS AND METHODS 
2.1. Culture of FRTLs cells 
FRTLs cells were grown in Coon’s modified 
Hank’s F12 medium (Imperial Laboratories) con- 
taining 5% newborn calf serum (Gibco) as well as 
a mixture of TSH, insulin, hydrocortisone, 
transferrin, glycyl-L-lysine acetate and somato- 
statin (defined as 6 hormone medium, 6H) for 14 
days under 5% CO2 in air in a water-saturated in- 
cubator [ 1,2]. After 14 days growth in 6H medium, 
the cells were either (i) detached from their plastic 
supports using a mixture of trypsin, collagenase 
and chicken serum [ 11, washed, resuspended in 6H 
medium and recultured or (ii) 6H medium was 
replaced with 5H medium (6H medium without 
TSH) and culture continued for 4 days. 
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In the case of cultures in 6H medium followed 
by 5H medium, the cells were washed twice in 
Earle’s balanced salt solution (EBSS) without 
phenol red (Gibco) and then detached from the 
flasks using 3 mM EGTA in 20 mM Hepes, pH 
7.3. The cell suspensions were then washed once 
again with EBSS before further analysis. Cell 
viability was assessed by the method of Parks et al. 
[3] and found to be approx. 80%. 
In one series of experiments involving several 
passages, aslow growing line of cells with different 
morphology developed. Membranes prepared 
from these cells did not bind 1251-labelled TSH (see 
below) but they were used as an additional control 
in photoaffinity labelling studies. 
2.2. TSH preparations 
TSH was prepared from bovine pituitaries using 
described procedures [4,5]. The purified material 
conrained 70-80 units (MRC bovine TSH stan- 
dard) per mg of protein as judged by TSH receptor 
assay [5] and bioassay [6]. 
2.3. Preparation of ‘251-labelled TSH for receptor 
binding studies 
Highly purified bovine TSH (70-80 MRC units 
per mg of protein) was labelled with 1251 to a 
specific activity of 50 &i per /cg by the Iodogen 
method [5,7]. After receptor purification, the 
material was stored for up to 2 weeks at -70°C. 
2.4. Receptor binding with ‘251-labelled TSH 
FRTLs cells were grown in 6H medium for 14 
days and then in 5H medium for 4 days before be- 
ing detached from the culture flasks with 3 mM 
EGTA. After suspension (20 x lo6 per ml) in 
EBSS, aliquots of the cells were treated with tryp- 
sin (O-O.1 O70) for 15 min at room temperature 
followed by a 2-fold excess (w/w) of trypsin in- 
hibitor (10 min at room temperature). After 
washing in EBSS, a crude membrane fraction was 
prepared from homogenates of the cells (see sec- 
tion 2.7) and suspended in 50 mM NaCl; 10 mM 
Tris-HCl, pH 7.5; 1 mg-’ bovine serum albumin 
(membranes from 20 x lo6 cells per ml of suspen- 
sion buffer). *251-labelled TSH binding was then 
carried out by incubating triplicate 100 ~1 aliquots 
of the membrane suspension (membranes from 2 x 
lo6 cells per 100 ,ul) with 100~1 highly purified 
unlabelled TSH (O-O.5 pg) and 100 ,ul of receptor 
purified 1251-labelled TSH (5000 cpm) for 1 h at 
37°C. Bound and free labelled TSH were then 
separated by addition of 500 pl of ice-cold suspen- 
sion buffer and centrifugation at 15000 x g for 
20 min. 
2.5. Preparation of “‘I-HSAB- TSH for 
crosslinking studies 
Highly purified bovine TSH was coupled to the 
photoactive hetero-bifunctional reagent N-hy- 
droxysuccinimidyl-4azidobenzoate (HSAB) as 
described [8]. After labelling with “‘1 to a specific 
activity of 50 &i per /cg by the Iodogen method 
[5,7], the material (‘251-HSAB-TSH) was purified 
by gel filtration [5] and stored at -70°C for up to 
2 weeks. 
2.6. Crosslinking of ‘251-HSAB- TSH to TSH 
receptors on intact FRTL5 cells 
After washing in EBSS, the cells (20 x 106) were 
suspended in 1 ml of EBSS without phenol red and 
incubated in the dark at 37”C, with an equal 
volume of ‘251-HSAB-TSH (20 pCi) for 20 min. In 
some experiments, unlabelled bovine TSH (5 pg; 
350 mu) was added to the cell suspension 5 min 
prior to addition of 1251-HSAB-TSH. The material 
was then photolysed for 15 min, 14 cm from a 
250 W UV lamp to effect crosslinking and the cells 
washed twice in 20 ml of EBSS. 
2.7. Preparation of FRTLs cell membranes 
The affinity labelled cells (or in some cases un- 
treated cells) were first homogenized in 10 mM 
Tris-HCl, pH 7.5, containing 0.1 mM phenyl- 
methylsulphonyl fluoride (PMSF) and 15 mM 
iodoacetamide. A crude membrane fraction was 
then sedimented bycentrifugation at 14000 x g for 
10 min at 4°C and used for further analysis. In 
some experiments, a crude membrane fraction was 
also prepared from homogenates of normal Fisher 
rat thyroid tissue. 
2.8. Solubilization of crosslinked TSH-TSH 
receptor complexes with sodium deoxycholate 
Membranes containing TSH receptors cross- 
linked to ‘251-HSAB-TSH were homogenized in 
1% sodium deoxycholate (DOC) in 50 mM NaCl; 
10 mM Tris-HCl, pH 8.3, containing 0.1 mM 
PMSF (50 pl of 1% DOC per membrane pellet ob- 
tained from 20 x lo6 cells) and incubated at room 
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temperature for 30 min. After centrifugation 
(100000 x g, 1 h, 4°C) the supernatants were col- 
lected and analysed by SDS-PAGE and 
autoradiography as described below. 
3. RESULTS 
2.9. Reduction of membrane bound TSH-TSH 
receptor complexes with dithiothreitol 
Cell membranes containing TSH receptors 
crosslinked to iz51-HSAB-TSH were homogenized 
in 50 mM NaCl; 10 mM Tris-HCl, pH 8.3, con- 
taining 0.1 mM PMSF and 10 mM dithiothreitol 
(DTT) (50~1 per membrane pellet obtained from 
20 x lo6 cells) and incubated for 30 min at room 
temperature [9, lo]. Parallel experiments were car- 
ried out in which the membrane preparations were 
homogenized in buffer without DTT. The 
homogenates were then centrifuged at 100000 x g 
for 1 h at 4°C and the supernatants treated with a 
5-fold molar excess of iodoacetamide prior to 
analysis by SDS-PAGE and autoradiography. 
Trypsin treatment of FRTLs cell suspensions did 
not affect their viability as judged by ethidium 
bromide exclusion. However, specific ‘251-TSH 
binding to the membranes prepared from trypsin- 
treated cells was markedly diminished, from 12% 
of counts added in the case of membranes from 
untreated cells to 3.8% with 0.01% trypsin and 
2.5% with 0.1% trypsin. Scatchard analysis [12] of 
TSH binding to membranes prepared from non- 
trypsin-treated FRTLs cells was carried out and 
showed linear plots (fig.1). Cells grown in 6H 
medium followed by 5H medium gave membrane 
preparations with an association constant of 3.7 x 
lo9 M-’ and binding capacity of 11 x lo3 sites per 
cell. Cells grown in 6H medium only gave mem- 
brane preparations with a similar association con- 
0.18 
1 
2.10. Crosslinking to membrane preparations 0.18 1” 
In some experiments, crude membrane fractions 
were prepared from FRTLs cells (20 x 10”) or nor- 
mal Fisher rat thyroid tissue (250 mg) and then af- 
finity labelled with lz51-HSAB-TSH (20 ,&i). 
After washing with suspension buffer (2 x 1 ml), 
containing 0.1 mM PMSF, the final pellets were 
treated with DTT or DOC in the same way as 
membrane pellets from affinity labelling of intact 
FRTL5 cells (see above). 
2.11. Gel electrophoresis and autoradiography 
Samples for analysis by SDS-PAGE were diluted 
in an equal volume of electrophoresis ample buf- 
fer (4% SDS in Tris-HCI buffer, pH 6.8, contain- 
ing 20% glycerol) with or without 10 mM DTT 
and analysed on 9% polyacrylamide gels [8-l 11. 
After electrophoresis gels were stained, fixed and 
set for autoradiography using Kodak X-OMAT 
film and Cronex Lighting Plus enhancing screens. 
The following M, markers were run on each gel: 
myosin (Mr 205 000), fl-galactosidase ( 116 OOO), 
phosphorylase b (97000), BSA (67000), im- 
munoglobulin G and its component heavy and 
light chains (150000, 50000 and 23000, respective- 
ly) and ovalbumin (44000). Analysis under reduc- 
ing and non-reducing conditions used reduced and 
non-reduced standard proteins, respectively. 
Fig. 1. Scatchard analysis of TSH binding to membranes 
prepared from FRTLs cells grown in 6H medium only 
(0) or 6H medium followed by 5H medium (0). See text 
for experimental details. Data for each point were 
obtained using membranes from 2 x lo6 cells (in 
duplicate). Non-specific binding was determined using 
0.15 pg (10 mu) of unlabelled TSH. The data shown are 
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stant (4 x lo9 M-l) but markedly lower binding 
capacity (4 x lo3 sites per cell). 
When TSH receptors on FRTLs cells were affini- 
ty labelled with 12’1-HSAB-TSH and the mem- 
branes from these cells treated with DTT, analysis 
by SDS-PAGE and autoradiography showed the 
presence of a major labelled band at 80 kDa 
(fig.2). Additional labelled bands at 28 and 14 kDa 
corresponding to intact TSH and TSH subunits 
respectively were also present. The 80 kDa band 
was not observed when FRTLs cells were incubated 
with 5 pg (350 mu) of unlabelled TSH prior to ad- 
dition of 1251-labelled HSAB-TSH (fig.2a) or when 
membranes from affinity labelled cells (in the 
absence of unlabelled TSH) were homogenized in 
buffer rather than DTT (fig.2b). 
SDS-PAGE analysis of DOC solubilized mem- 
branes from affinity labelled FRTLs cells under 
non-reducing conditions is shown in fig.3a. In ad- 
50K 
28K 28K 
b 1 2 
Fig.2. Effect of DTT on membranes prepared from 
affinity labelled FRTLs cells. (a) Lanes: 1, membranes 
treated with DTT, centrifuged (100000 x g) and 
supernatant analysed by SDS-PAGE and autoradio- 
graphy; 2, as lane 1 except cells incubated with an excess 
of unlabelled TSH prior to addition of ‘251-HSAB-TSH 
and photolysis. (b) Lane 1: as lane 1 in a. Lane 2: as lane 
1 in a except DTT omitted from buffer used to 
homogenize membranes. The material applied to each 
lane was derived from 10 x lo6 cells. 
148K _) 
85K - 
28K 
b 
1 2 
Fig.3. Analysis of DOC solubilized membranes prepared 
from affinity labelled FRTLs cells. (a) SDS-PAGE 
under non-reducing conditions followed by autoradio- 
graphy. The bands at 150, 120 and 80 kDa were not 
detected in experiments in which cells were incubated 
with an excess of unlabelled TSH prior to addition of 
r2’I-HSAB-TSH and photolysis. (b) SDS-PAGE under 
reducing conditions followed by autoradiography. 
Lanes: 1, DOC solubilized membranes from affinity 
labelled FRTL5 cells; 2, DOC solubilized membranes 
from affinity labelled mutant FRTL5 cells which did not 
have detectable TSH receptors (see text for details). The 
140 and 85 kDa bands shown in lane 1 were not detected 
in experiments in which cells were incubated with an 
excess of unlabelled TSH prior to addition of 12’1- 
HSAB-TSH and photolysis; the results being very 
similar to that shown in lane 2. The material applied to 
each lane was derived from 10 x lo6 cells. 
dition to TSH, major bands at 120 kDa and about 
150 kDa were observed and a weak band at 
80 kDa. Under reducing conditions, the 120 kDa 
band was not seen, but clear labelled bands were 
present at 140 and 85 kDa (fig.3b). The formation 
of the non-TSH bands was not observed in DOC 
solubilized membranes prepared from cells in- 
cubated with 5 fig/350 mU of unlabelled TSH 
prior to ‘251-labelled HSAB-TSH (not shown). 
Furthermore, no bands additional to TSH were 
observed in crosslinking experiments with mutant 
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FRTLs cells which did not have detectable TSH 
receptors. 
A summary of the data obtained by SDS-PAGE 
and autoradiography is given in table 1. 
In an additional series of experiments mem- 
branes were isolated from FRTLs cells and then af- 
finity labelled with “‘I-HSAB-TSH. Analysis by 
SDS-PAGE and autoradiography of the super- 
natants obtained after treatment with DTT or 
DOC and centrifugation gave similar results to 
those obtained when affinity labelling was carried 
out using intact cells (table 1). However, the bands 
were less intense. Studies with membranes 
prepared from normal Fisher rat thyroid tissue 
gave even weaker bands but in one experiment 
release of 80 kDa material by DTT could be seen 
clearly (not shown). 
4. DISCUSSION 
Trypsin treatment of FRTLj cells did not in- 
fluence cell viability but markedly diminished the 
ability of membranes prepared from the cells to 
bind labelled TSH. This indicated that the cell’s 
TSH receptors were principally present on the cell 
surface. Scatchard analysis [12] of membranes 
prepared from FRTLs cells suggested the presence 
of a single population of low capacity high-affinity 
TSH binding sites. The number of binding sites 
was markedly increased in membranes prepared 
from cells cultured for 4 days in the absence of 
TSH as reported [ 131. Consequently, our results 
support the conclusion of this report that TSH 
down-regulates its own receptor in FRTLs cells. 
When TSH receptors on FRTLs cells were affini- 
ty labelled with 1251-labelled HSAB-TSH and 
treated with the reducing agent DTT in the absence 
of detergent, a water-soluble component (M 
80000) of the TSH receptor crosslinked to TSH 
was released. Similar results have been observed 
after DTT treatment of affinity labelled TSH 
receptors in membranes prepared from human, 
porcine and guinea pig thyroid tissue and from 
guinea pig fat [f&10,14,15]. Consequently, our 
data indicate that the FRTL5: cell TSH receptor 
contains a water-soluble subunit (defined as the A 
subunit) with h4, 50000-55000 (after subtraction 
of M, 28000 for TSH from M, 80000 for the A 
subunit TSH complex). Our studies also indicated 
that TSH receptors in normal Fisher rat thyroid 
membranes contained a water-soluble A subunit 
with Mr 50000-55000. 
The results obtained with DOC solubilized, af- 
finity labelled, FRTLs cell TSH receptors however 
showed some differences from those observed with 
porcine or human thyroidal TSH receptors 
120K QOK 
A subunit (55K) 
TSH 
binding site-: 
j _ii 
Proteolysis ? Reduction 
S 
transmembrane 
section - 
I 1 
B subunit (35K) 
A & B subunits 
Single chain linked by a Seperate 
3 precursor receptor disulphide bridge A (L B subunits 
Fig.4. Proposed relationship between different forms of the FRTLs TSH receptor. 
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[8-10,14,15]; in particuar the presence of a major 
broad band at Mr 150000 in addition to a major 
band at Mr 120000 and minor band at Mr 80000 
under non-reducing conditions (fig.3). The band 
of Mr 150000 showed only a minor change in Mr 
value (to 140000) on reduction indicating that it 
did not contain any major subunits linked by 
disulphide bridges. The band of Mr 120 000 showed 
a marked change in Mr value (to 85 000) on reduc- 
tion and the material ran on the gels essentially as 
the A subunit of  the receptor crosslinked to TSH 
(Mr 80000). The slightly higher Mr of A subunit- 
TSH complex derived from DOC solubilized mem- 
branes (86000 + 4000) compared to complex 
prepared by treatment of membranes by DTT in 
the absence of DOC (80000 + 4000) was consis- 
tent. This difference could have been due to con- 
tinued association of some DOC micelles with the 
A subunit-TSH complex during SDS-PAGE in the 
case of studies with DOC solubilized preparations. 
The intensity of the minor band at 80 kDa under 
non-reducing conditions was markedly increased if
iodoacetamide was omitted from the homogeniza- 
tion buffers, suggesting that this 80 kDa band 
could possibly be formed by the actions of an en- 
dogenous reducing system on 120 kDa material. 
Overall, our observations suggest that the 
120 kDa band shown in fig.3a consists of: 
(i) TSH (Mr 28000) crosslinked to the A subunit 
of  the TSH receptor; and 
(ii) an amphiphilic B subunit (Mr 35000) which 
does not bind TSH, but is linked to the A 
subunit by a disulphide bridge. The B subunit 
must also contain the trans-membrane s ction 
of the 120 kDa band. 
It seems likely that the TSH receptor component 
of the 150 kDa band is a precursor of the A and B 
subunit form present in the 120 kDa band as 
shown in fig.4. We can propose that the precursor 
form of the receptor consists of a single peptide 
chain (Mr 120000) with a loop of amino acids 
formed by a disulphide bridge (fig.4). Proteolytic 
cleavage of peptide bonds within the loop of amino 
acids then gives rise to a form of the receptor in 
which 2 subunits (A and B) are linked by the 
disulphide bridge which originally formed the loop 
(fig.4). Reduction of the disulphide bridge then 
allows release of the water-soluble A subunit. This 
type of processing is well established in the cases of 
several proteins including insulin and influenza 
virus hemagglutinin [16]. Any differences in affini- 
ty between the 'precursor' and 'processed' forms 
of the receptor were not evident from Scatchard 
analysis of TSH binding data (fig.l). 
The single chain precursor form of the receptor 
was not detected in previous tudies of crosslinked 
Table 1 
Summary of results obtained by SDS-PAGE analysis of affinity labelled TSH receptors 
Method used Major labelled bands observed on SDS-PAGE additional to TSH 
to treat affinity (mean Mr +_ SD) 
labelled 
preparations Bands of Mr 150000 Bands of Mr 120000 Bands of Mr 80000 
Crosslinking Crosslinking Crosslinking Crosslinking Crosslinking Crosslinking 
to intact to membrane to intact to  membrane to intact to membrane 
cells preparations cells preparations cells preparations 
DTT in the absence ND ND 
of detergent 
DOC in the absence 154000+_3000 150000 
of DTT (n = 4) (n = 1) 
DOC followed by 139000+_ 137000 
DTT 10000 (n = 1) 
(n = 6) 
ND ND 80000___ 4000 80000 
(n = 5) (n = 1) 
119000+2000 119000 minor band minor band 
(n = 4) (n = 1) at Mr 85000 at Mr 86000 
(n = 4) (n = 1) 
ND ND 86000 _ 4000 86000 
(n = 6) (n = 1) 
ND, not detected; n, number of separate xperiments 
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TSH-TSH receptor complexes prepared from 
human, porcine and guinea pig thyroid or guinea 
pig fat cell membranes [8-10,14,15]. However, it 
is likely that the 2-chain structure observed in these 
tissues is synthesised initially as a single polypep- 
tide chain precursor molecule of the type shown in 
fig.4 [16]. 
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